Personalized Medicine: Leave no Patient Behind; Report From the 2024 Coffey‐Holden Prostate Cancer Academy Meeting
This article summarizes the presentations and discussions from the 2024 CHPCA Meeting. We hope that sharing this knowledge will inspire and accelerate research into new discoveries and solutions for prostate cancer.
Authors
- Roni Haas (ORCID: https://orcid.org/0000-0003-1505-2965)
- Laura A. Sena (ORCID: https://orcid.org/0000-0001-6724-9546)
- Marina N. Sharifi (ORCID: https://orcid.org/0000-0003-0128-3033)
- Lisa N. Chesner (ORCID: https://orcid.org/0009-0007-2779-8824)
- Howard R. Soule (ORCID: https://orcid.org/0000-0003-2255-2298)
- Asmaa Elsayed Elkenawi
- Alok K. Tewari (ORCID: https://orcid.org/0000-0003-2617-7499)
- Kenneth J. Pienta (ORCID: https://orcid.org/0000-0002-4138-2186)
- Andrea K. Miyahira (ORCID: https://orcid.org/0000-0003-4976-002X)
Institutions
- Indiana University Health (US)
- University of Wisconsin–Madison (US)
- Johns Hopkins University (US)
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Prostate Cancer Foundation (US)
- University of Wisconsin Carbone Cancer Center (US)
- Dana-Farber Cancer Institute (US)
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- The Prostate
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1002/pros.24826
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.42